Efsubaglutide injection every 2 weeks for Type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new injectable medicine (efsubaglutide alfa) given once every two weeks to help control blood sugar in people with Type 2 diabetes who have not taken diabetes medications for at least 8 weeks. It aims to see if it is safe and works better than a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have Type 2 diabetes and have not taken any diabetes medicine in the last 8 weeks.
- Your HbA1c (average blood sugar over 3 months) is between 7.5% and 11.0%.
- Your fasting blood sugar is 250 mg/dL or lower (13.9 mmol/L).
- Your body mass index (BMI) is between 19 and 35.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called UBT251 for people with type 2 diabetes whose blood sugar is not well controlled despite taking metformin, either alone or with another diabetes medicine. The goal is to see if it can lower blood sugar levels more than a placebo.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This trial tests an investigational medication (HS-20094) for people with type 2 diabetes. It aims to see if it can help control blood sugar and possibly support weight loss.
This is an early-stage safety study testing a new medication called efsubaglutide in healthy adults. Researchers want to make sure it is safe and understand how the body processes it.
This study tests a new weekly injection, efsubaglutide alfa (a GLP-1 drug), for helping people with overweight or obesity lose weight. It is for people who have not been able to lose weight with diet and exercise alone and do not have other serious health conditions.
This study tests a new long-acting form of semaglutide (a diabetes medication you may already take weekly) given as a depot injection. Researchers want to see if this new form is safe and works better for managing type 2 diabetes.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.